Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting

被引:15
作者
Mayersbach, Peter [1 ]
Fuchs, Dietmar [2 ]
Schennach, Harald [1 ]
机构
[1] Univ Innsbruck Hosp, Cent Inst Blood Transfus & Immunol, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Div Biol Chem, Innsbruck, Austria
关键词
blood donations; ELISA; neopterin; performance; screening; SERUM NEOPTERIN; VIRUS; TRANSFUSION; INFECTIONS; PREVALENCE; RELEASE; MARKER;
D O I
10.1515/CCLM.2010.072
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Acute virus infections are indicated by increased serum neopterin concentrations. Testing of blood donations for increased neopterin was introduced in the Austrian Tyrol in 1986 and throughout Austria in 1994 to improve the safety of blood transfusions. Radioimmunoassay (RIA) was the first available test, and the 98th percentile for neopterin concentrations from 76,500 donations was defined as the cut-off threshold, excluding donations with neopterin >= 10 nmol/L. When ELISAs were introduced on fully automated test systems to measure neopterin concentrations, results were generally higher and the cut-off was adjusted up to 12 nmol/L. Methods: In early 2006, new equipment (Hamilton Microlab Star (R) pipettor+Dade Behring ELISA Processor III, BEP III (R)) became available which monitors sample and reagent volumes for each uptake and dispense, and takes the viscosity of the fluids into account. Using this system, the performance of neopterin determinations was evaluated over 21 months and compared to earlier data. Results: When the new apparatuses were introduced, an immediate decrease in mean neopterin concentrations and the percentage of samples with neopterin concentrations >= 10 nmol/L was observed. The 55,516 measurements performed in 2007 showed a mean value of 5.5 nmol/L. Neopterin in 680 donations (1.23%) were >= 10 nmol/L. Conclusions: The new Hamilton diluter increased the accuracy of the neopterin test procedure. Results are now identical with those of RIA and ELISA when run in a semi-automated manner. Differences in pipetting performance of standards and samples are considered as one possible explanation for the earlier discrepancies seen with the automated apparatus. Clin Chem Lab Med 2010;48:373-7.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 20 条
[1]   Pathogen reduction: A precautionary principle paradigm [J].
Alter, Harvey J. .
TRANSFUSION MEDICINE REVIEWS, 2008, 22 (02) :97-102
[2]   Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris [J].
Avanzas, P ;
Arroyo-Espliguero, R ;
Quiles, J ;
Roy, D ;
Kaski, JC .
EUROPEAN HEART JOURNAL, 2005, 26 (05) :457-463
[3]   The value of increased neopterin levels in reducing transfusion-transmitted virus infections: Detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors [J].
Fisenk, BI ;
Us, D ;
Ozcebe, OI ;
Hascelik, G .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (08) :599-604
[4]   NEOPTERIN AS A MARKER FOR ACTIVATED CELL-MEDIATED-IMMUNITY - APPLICATION IN HIV INFECTION [J].
FUCHS, D ;
HAUSEN, A ;
REIBNEGGER, G ;
WERNER, ER ;
DIERICH, MP ;
WACHTER, H .
IMMUNOLOGY TODAY, 1988, 9 (05) :150-155
[5]   THE ROLE OF NEOPTERIN AS A MONITOR OF CELLULAR IMMUNE ACTIVATION IN TRANSPLANTATION, INFLAMMATORY, INFECTIOUS, AND MALIGNANT DISEASES [J].
FUCHS, D ;
WEISS, G ;
REIBNEGGER, G ;
WACHTER, H .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1992, 29 (3-4) :307-341
[6]   IMMUNOLOGICAL CHANGES IN PRIMARY HIV-1 INFECTION [J].
GAINES, H ;
VONSYDOW, MAE ;
VONSTEDINGK, LV ;
BIBERFELD, G ;
BOTTIGER, B ;
HANSSON, LO ;
LUNDBERGH, P ;
SONNERBORG, AB ;
WASSERMAN, J ;
STRANNEGARD, OO .
AIDS, 1990, 4 (10) :995-999
[7]   Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study [J].
Grammer, Tanja B. ;
Fuchs, Dietmar ;
Boehm, Bernhard O. ;
Winkelmann, Bernhard R. ;
Maerz, Winfried .
CLINICAL CHEMISTRY, 2009, 55 (06) :1135-1146
[8]   Neopterin: a review [J].
Hamerlinck, FFV .
EXPERIMENTAL DERMATOLOGY, 1999, 8 (03) :167-176
[9]   DETERMINATION OF SERUM NEOPTERIN TO INCREASE THE SAFETY OF DONATED BLOOD FOR TRANSFUSION - RESULTS IN 76587 BLOOD-DONORS [J].
HONLINGER, M ;
FUCHS, D ;
HAUSEN, A ;
REIBNEGGER, G ;
SCHONITZER, D ;
WERNER, ER ;
REISSIGL, H ;
DIERICH, MP ;
WACHTER, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (05) :172-176
[10]   NEOPTERIN SCREENING AND ACUTE CYTOMEGALOVIRUS INFECTIONS IN BLOOD-DONORS [J].
HONLINGER, M ;
FUCHS, D ;
REIBNEGGER, G ;
SCHONITZER, D ;
DIERICH, MP ;
WACHTER, H .
CLINICAL INVESTIGATOR, 1992, 70 (01) :63-63